BMAL1–HIF2A heterodimer modulates circadian variations of myocardial injury

Acute myocardial infarction is a leading cause of morbidity and mortality worldwide<sup>1</sup>. Clinical studies have shown that the severity of cardiac injury after myocardial infarction exhibits a circadian pattern, with larger infarcts and poorer outcomes in patients experiencing morning-onset events<sup>2-7</sup>. However, the molecular mechanisms underlying these diurnal variations remain unclear. Here we show that the core circadian transcription factor BMAL1<sup>7-11</sup> regulates circadian-dependent myocardial injury by forming a transcriptionally active heterodimer with a non-canonical partner-hypoxia-inducible factor 2 alpha (HIF2A)<sup>12-16</sup>-in a diurnal manner. To substantiate this finding, we determined the cryo-EM structure of the BMAL1-HIF2A-DNA complex, revealing structural rearrangements within BMAL1 that enable cross-talk between circadian rhythms and hypoxia signalling. BMAL1 modulates the circadian hypoxic response by enhancing the transcriptional activity of HIF2A and stabilizing the HIF2A protein. We further identified amphiregulin (AREG)<sup>16,17</sup> as a rhythmic target of the BMAL1-HIF2A complex, critical for regulating daytime variations of myocardial injury. Pharmacologically targeting the BMAL1-HIF2A-AREG pathway provides cardioprotection, with maximum efficacy when aligned with the pathway's circadian phase. These findings identify a mechanism governing circadian variations of myocardial injury and highlight the therapeutic potential of clock-based pharmacological interventions for treating ischaemic heart disease.

Authors

Institutions

Publication Details

Journal
Nature
Published
2025-04-23
DOI
https://doi.org/10.1038/s41586-025-08898-z
Citations
35
Primary Topic
Circadian rhythm and melatonin
Type
article
Field-Weighted Citation Impact
31.10
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

BMAL1–HIF2A heterodimer modulates circadian variations of myocardial injury

Jagat Narula, Holger K. Eltzschig, Joshua Gorham, Xiaoyi Yuan et al.
35 citations
Nature
Circadian rhythm and melatonin
31.10
article

BMAL1–HIF2A heterodimer modulates circadian variations of myocardial injury

Jagat Narula, Holger K. Eltzschig, Joshua Gorham, Xiaoyi Yuan, Christine E. Seidman, Zhongming Zhao, Yafen Liang, Matthew DeBerge, Katherine Figarella, Boyun Kim, Dongze Zhang, Jonathan G. Seidman, Sary F. Aranki, Xinxin Ma, Kuang‐Lei Tsai, Wankun Deng, Seung‐Hee Yoo, Jochen D. Muehlschlegel, Yin‐Ying Wang, In Hyuk Bang, Wei Ruan, Yu An, Alemayehu A. Gorfe, Fang Du, Jae W. Lee, Lei Li, Tao Li, Zhen Zhou, Yanyu Wang, Jiwen Li, Cong Luo, Ragini Nair
article en
35 citations

Abstract

Acute myocardial infarction is a leading cause of morbidity and mortality worldwide<sup>1</sup>. Clinical studies have shown that the severity of cardiac injury after myocardial infarction exhibits a circadian pattern, with larger infarcts and poorer outcomes in patients experiencing morning-onset events<sup>2-7</sup>. However, the molecular mechanisms underlying these diurnal variations remain unclear. Here we show that the core circadian transcription factor BMAL1<sup>7-11</sup> regulates circadian-dependent myocardial injury by forming a transcriptionally active heterodimer with a non-canonical partner-hypoxia-inducible factor 2 alpha (HIF2A)<sup>12-16</sup>-in a diurnal manner. To substantiate this finding, we determined the cryo-EM structure of the BMAL1-HIF2A-DNA complex, revealing structural rearrangements within BMAL1 that enable cross-talk between circadian rhythms and hypoxia signalling. BMAL1 modulates the circadian hypoxic response by enhancing the transcriptional activity of HIF2A and stabilizing the HIF2A protein. We further identified amphiregulin (AREG)<sup>16,17</sup> as a rhythmic target of the BMAL1-HIF2A complex, critical for regulating daytime variations of myocardial injury. Pharmacologically targeting the BMAL1-HIF2A-AREG pathway provides cardioprotection, with maximum efficacy when aligned with the pathway's circadian phase. These findings identify a mechanism governing circadian variations of myocardial injury and highlight the therapeutic potential of clock-based pharmacological interventions for treating ischaemic heart disease.

NatureVol. 641(8064)
Brigham and Women's Hospital (US), Memorial Hermann (US), The University of Texas MD Anderson Cancer Center (US), Harvard University (US), Central South University (CN), Johns Hopkins University (US), Sun Yat-sen University (CN), Fudan University (CN), Johns Hopkins Medicine (US), Sir Run Run Shaw Hospital (CN), Yale University (US), Shenzhen Bay Laboratory (CN), Zhongshan Hospital (CN), The First Affiliated Hospital, Sun Yat-sen University (CN), Second Xiangya Hospital of Central South University (CN), The University of Texas Health Science Center (US), Zhejiang University (CN), Pukyong National University (KR), The University of Texas Health Science Center at Houston (US)
Good health and well-being, No poverty
Openalex Percentile: Top 0%
Circadian rhythm and melatonin
31.10
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.